Cardiol Therapeutics Inc. Amortisation Expense
Cardiol Therapeutics Inc. (CRDL) reported Amortisation Expense of CAD 210.36 thousand for the 12-month period ending 2024-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Operating Expenses
ifrs-full:AmortisationExpense · last filed 2026-03-31
| Period end | Amortisation Expense 12 month |
|---|---|
| 2024-12-31 | 210.36K CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 84.44K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 84.44K CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 84.44K CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 84.44K CAD 20-F · filed 2023-03-29 |